North Health Ltd. raised $6 million in financing to bring its oncology products to the market including the Neutrocheck, a ...
A ketone body, a molecule derived from the metabolism of acids to obtain energy when glucose is not available, could become ...
Dewpoint Therapeutics Inc. and Mitsubishi Tanabe Pharma Corp. have entered a research collaboration worth up to $480 million ...
Voyager Therapeutics Inc.’s recent selection of a lead development candidate, VY-1706, for its tau silencing gene therapy program in Alzheimer’s disease brought renewed attention to the target, which ...
Methods that may work well for recruiting and retaining white patients for clinical trials may need to be adjusted to ...
Sunshine Biopharma Inc. has completed mouse model studies providing proof of concept for the company’s K1.1 mRNA product as a ...
A federal jury awarded Insulet Corp. $452 million against Eoflow Co. Ltd., concluding that Eoflow and other defendants stole ...
Spur Therapeutics Ltd. has selected SPR-301 as lead development candidate from its gene therapy program for a genetically ...
Bring your dog to work day looks a little different at Spotitearly. The Tel Aviv-based company asks its canine workers to bring their whole selves to the job – particularly their finely trained noses ...
Beijing Hanmi Pharm. Co. Ltd. broke ground on a â‚©140 billion (US$98.65 million) large-scale project to build a near-500,000-square-foot China base near Beijing Capital International Airport in efforts ...
Ferroptosis is a programmed cell death mechanism driven specifically by lipid peroxidation. Previous research found that ...
Biopharma companies have raised $97.42 billion through November 2024, up 46% from $66.79 billion during the same period in 2023 and also more than $56.56 billion in 2022. However, this year’s total ...